◆ TICKERBASEOpen interactive view →
◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

HomeAll stocksB › BIOT

Instinct Bio Technical Company Holdings Inc. (BIOT) Financial History

4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

Consumer Defensive · Household & Personal Products · DATA UPDATED 2026-09-08

Instinct Bio Technical Company Holdings Inc. (BIOT) operates in the Household & Personal Products industry and is headquartered in Tokyo, Japan. Its market capitalization is roughly $11 million. In the fiscal year ended 2024-11-30, BIOT reported $3M in revenue and $0M in net income.

Instinct Bio Technical Company Holdings Inc. focuses on stem cell and regenerative medicine-related products, wellness, and beauty encompassing from research and development, manufacturing, branding, and distribution. It has a strategic collaboration with PT Parva Candela to develop cosmetics business in Indonesia.

Interactive charts & full statements →

BIOT Revenue & Earnings History — Annual Income Statement

Income statement2024-11-302023-11-30
Total Revenue$3M$3M
Gross Profit$2M$3M
Operating Income (EBIT)($0M)$0M
Net Income$0M$0M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

BIOT Free Cash Flow History

Cash flow2024-11-302023-11-30
Dividends Paid$0M$0M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

BIOT Balance Sheet History

Balance sheet2024-11-302023-11-30
Total Assets$3M$3M
Total Liabilities$1M$1M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive BIOT viewer.

Other Companies in Household & Personal Products

← BIONAll “B” companiesBIOTEC →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.